← All trials
NCT06000514
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 17, 2019
- Primary completion
- Apr 6, 2022
- Completion date
- Jul 7, 2022
- First posted
- Aug 21, 2023
- Last posted
- Aug 21, 2023
- Enrollment
- 20
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Federal University of BahiaLead sponsor
- Conselho Nacional de Desenvolvimento Científico e TecnológicoCollaborator
- Federal University of BahiaReponsible party - principal investigator
- Federal University of Minas GeraisOverall official - principal investigator
- Oswaldo Cruz FoundationCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.